Cargando…
A Remarkable Clinical Response to Pembrolizumab in a Rare Spindle Cell Carcinoma of the Lung
Spindle cell carcinoma of the lung consists of only spindle-shaped tumor cells, and accounts for approximately 13.3% of all sarcomatoid carcinomas (SCs), which are a rare subtype of poorly differentiated non-small cell lung cancer (NSCLC). Spindle cell carcinoma of the lung has very poor prognosis o...
Autores principales: | Tsurumi, Kyoji, Kawashima, Yosuke, Akahira, Junichi, Saito, Ryohei, Toi, Yukihiro, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro, Sugawara, Shunichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733742/ https://www.ncbi.nlm.nih.gov/pubmed/33324781 http://dx.doi.org/10.31662/jmaj.2019-0015 |
Ejemplares similares
-
Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
por: Sugisaka, Jun, et al.
Publicado: (2019) -
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge
por: Sugisaka, Jun, et al.
Publicado: (2023) -
Gene expression signatures as candidate biomarkers of response to PD-1 blockade in non-small cell lung cancers
por: Aiba, Tomoiki, et al.
Publicado: (2021) -
Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer
por: Ono, Kana, et al.
Publicado: (2021) -
Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment
por: Kondo, Yasuteru, et al.
Publicado: (2022)